Intelerad Medical Systems, a medical imaging software company, has agreed to acquire Ambra Health, a cloud-based medical imaging software provider. Intelerad, backed by European buyout

Intelerad Medical Systems, a medical imaging software company, has agreed to acquire Ambra Health, a cloud-based medical imaging software provider. Intelerad, backed by European buyout
DeepSight Technology, a diagnostic medical imaging platform, announced a $25 million Series A led by Deerfield Management Company, a healthcare investment firm, with additional funding
Ultromics, an AI-enabled cardiovascular imaging solutions provider, raised $33 million in a Series B funding round. The Blue Venture Fund led the round with Optum
The digital X-ray company Nanox agreed to acquire Zebra Medical Vision, which develops an AI-powered medical imaging platform that spots breast cancer, brain bleeds, and
Exo Imaging, a developer of AI-enabled medical imaging and therapeutic applications, closed a $220 million Series C investment round led by RA Capital Management. BlackRock,
Eyenuk, a medical imaging company that provides an AI-powered eye screening system for autonomous detection of diabetic retinopathy, completed a financing round of $6.2 million
Aidoc, an AI-powered medical imaging company, announced a $66 million investment round, bringing its total funding to $140 million. General Catalyst led the Series C
Cleerly, an AI-powered medical imaging company creating a new standard of care for coronary artery disease, raised $43 million in Series B funding. Vensana Capital
Promaxo, an AI-powered medical imaging enhancement platform, announced the closing of an investment round of $4.17 million led by Huami. The medical technology company plans
Subtle Medical, a provider of AI-powered solutions for vendor-agnostic medical imaging enhancement, raised $12.2 million in a Series A funding round, led by 3E Bioventures